FDA Greenlights New Eylea Formulation for Wet AMD, DME, and DR
The US Food and Drug Administration (FDA) has granted clearance for the new 8 mg formulation of Eylea (aflibercept), marking a significant milestone in the treatment... Read more.
When ‘Natural’ Isn’t Safe: Lead Poisoning and Ayurvedic Supplement Use
A woman’s journey toward becoming pregnant took an unexpected turn as it resulted in lead poisoning due to her use of Ayurvedic treatment. This incident prompted... Read more.
Are Medication Errors 100% Preventable?
Medication errors, unfortunately, are an ever-present concern in healthcare systems around the world. These errors encompass a wide range of mistakes, from incorrect... Read more.
Regeneron’s Breakthrough Treatment, Veopoz, Granted FDA Approval for Rare Disease
In a significant development, Regeneron Pharmaceuticals, Inc. has announced the approval of Veopoz™ (pozelimab-bbfg) by the U.S. Food and Drug Administration (FDA).... Read more.
Can I Use Clotrimazole And Hydrocortisone Creams Together For Skin Conditions?
Drug-drug interactions occur as a consequence of the complex interplay between various medications, where two or more drugs interact with one another in ways that... Read more.
List of Drugs That Cause Hypersexuality
Hypersexuality also known as compulsive sexual behavior or sexual addiction is an excessive preoccupation with sexual fantasies, urges, or behaviors that are difficult... Read more.
List Of Beverages And Foods That Reduce Anxiety And Depression
Anxiety and depression are two of the most prevalent mental health disorders worldwide, affecting a significant portion of the global population. Anxiety disorders,... Read more.
MSF Challenges GSK’s Contract Clauses for Access to Apretude
Médecins Sans Frontières (MSF), an international medical humanitarian organization, has been diligently working to secure access to ViiV Healthcare’s innovative... Read more.
Tukysa’s Trial Success Spurs Roche’s Kadcyla and Pfizer’s $43B Acquisition
Pfizer’s strategic move to acquire Seagen for $43 billion is primarily motivated by the Seattle biotech’s advantage in the field of antibody-drug conjugates... Read more.
FDA Issues Warning to AstraZeneca for Misleading COPD Drug Advertising
The absence of any drug that demonstrates a significant improvement in all-cause mortality among patients with chronic obstructive pulmonary disease (COPD) is a... Read more.